Webinar: Driving Value in Pharmacovigilance

Felix Arellano
Global Head of Drug Safety – Roche

‘From Planning to Launch: How to Implement a New Safety Database and Maximize ROI’

Hans van Leeuwen
Global Head of Regulatory Operations – Astellas

‘Achieving Interoperable Safety and Regulatory Platforms’

Julie Thomas
Vice President, Global Medical Safety Operations – Johnson & Johnson

‘LifeSphere NavaX: Driving Greater Value with GenAI’

Webinar

Driving Value in Pharmacovigilance

In this engaging panel discussion, global leaders in pharmaceutical IT and pharmacovigilance share their expertise on how to get the most value out of technology investments, achieving significant efficiency and cost savings.

The session provides practical advice and best practices for setting clear goals, advocating for ongoing investment in new technologies, and maximizing the value delivered through pharmacovigilance technology investments. The panelists present real-world examples and actionable takeaways that you can apply within your own organization to drive investment and transformation.

Key topics include:

Establishing clear goals, strategies, and metrics for success

Reporting on the value of investment and change

Advocating for continued investment

Access the recording now to gain insights and actionable strategies from this thought-provoking discussion!

"*" indicates required fields

First Name*

Last Name*

Email*

Job Title*

Company Name*

HQ Country*

Demo signup

Comments

This field is for validation purposes and should be left unchanged.

Please view our Privacy Policy for information on how ArisGlobal handles customer data.

LifeSphere® Technology is trusted by these industry leaders:

Mladen Prenc2024-12-12T14:05:31+00:00

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.

Quick Links

Follow Us